Chronic Wound Care Market Forecasts to 2030 – Global Analysis By Product (Surgical Wound Care and Traditional Wound Care), By Type (Wounds and Ulcers), Application, End User and By Geography
According to Stratistics MRC, the Global Chronic Wound Care Market is accounted for $13.49 billion in 2023 and is expected to reach $24.34 billion by 2030 growing at a CAGR of 8.8% during the forecast period. The chronic wound care market encompasses products and services aimed at treating persistent wounds, like pressure, diabetic, venous, and arterial ulcers. It includes dressings, therapies, and specialized treatments addressing wound healing, infection control, and patient management.
According to the CDC’s National Diabetes Statistics report of 2020, the number of diabetes patients has increased to an estimated 34.2 million, which comprises about 10.5% of the total population.
Market Dynamics:Driver:Increasing number of diabetic patients
Diabetes often leads to complications such as diabetic ulcers, impairing normal wound healing processes. High glucose levels damage blood vessels and nerves, causing poor circulation and reduced sensation, increasing vulnerability to chronic wounds. Consequently, this drives the demand for advanced wound care solutions, including specialized dressings, therapies, and treatments, as healthcare focuses on managing diabetic-related wounds.
Restraint:Infection delayed healing in chronic wounds
Infections in chronic wounds impede the natural healing process by prolonging inflammation, damaging newly formed tissue, and creating a hostile environment for cell regeneration. Bacterial colonization and bio-film formation further exacerbate the issue, making treatment more complex. Additionally, the presence of infection not only delays wound healing but also increases the risk of complications, such as systemic infections or the need for more aggressive interventions like surgical debridement or antibiotic therapy.
Opportunity:Rising geriatric population and technological advancements
The increasing elderly population presents an opportunity in the market due to their higher susceptibility to chronic wounds. This demographic trend drives the demand for advanced wound care solutions. Concurrently, technological advancements, such as innovative dressings, bioengineered tissues, and telemedicine, enhance treatment effectiveness and accessibility. These advancements streamline care, improve wound management and offer novel therapeutic approaches. Combining the expanding elderly demographic with cutting-edge technologies fosters fertile ground for continuous innovation and growth in the market.
Threat:High cost of treatment and inadequate reimbursement policies
Expensive therapies, specialized dressings, and advanced technologies drive up treatment expenses. Inadequate reimbursement policies hinder patient access to these costly interventions, impacting healthcare providers and patients. This scenario potentially limits the adoption of innovative treatments, reduces the quality of care and burdens healthcare systems, which further restrains market growth.
Covid-19 Impact:
The COVID-19 pandemic disrupted the chronic wound care market profoundly. Healthcare resources were redirected to managing the pandemic, impacting regular wound care services. Restrictions on elective procedures and outpatient visits limit access to wound care. Supply chain disruptions affected the availability of wound care products. Additionally, pandemic significantly affected the delivery, accessibility, and utilization of chronic wound care services and products.
The surgical wound care segment is expected to be the largest during the forecast period
The surgical wound care segment is anticipated to dominate the market. Surgical wounds often require specialized care to minimize infection risk and promote healing. The rising number of surgical procedures globally contributes to the demand for postoperative wound management. Additionally, technological advancements in surgical wound care products and techniques enhance efficacy. This, coupled with a growing aging population and increasing chronic diseases requiring surgical interventions, is expected to drive the surgical wound care segment's substantial market share.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is anticipated to experience substantial growth in the market due to several factors. Hospitals serve as crucial centers for specialized wound care, equipped with advanced technologies and skilled healthcare professionals. Rising chronic conditions and an aging population increase the demand for wound care services, often necessitating hospitalization for severe cases. Moreover, hospitals offer comprehensive care, including surgical interventions, specialized therapies, and access to a multidisciplinary team, making them pivotal in addressing complex chronic wounds and fostering growth in this segment.
Region with largest share:
North America is poised to secure the largest market share due to its advanced healthcare infrastructure, extensive research initiatives, and high adoption rates of innovative wound care technologies. Moreover, a significant prevalence of chronic conditions, an aging population and lifestyle factors contribute to a substantial patient pool requiring wound care interventions. Additionally, favorable reimbursement policies and robust healthcare expenditures further drive the market.
Region with highest CAGR:
Asia Pacific's robust growth in the market is due to a growing elderly population and an increasing prevalence of chronic diseases. Additionally, improving healthcare infrastructure, expanding healthcare expenditure and rising awareness about advanced wound care technologies drive market expansion. Moreover, the region's large patient pool, coupled with initiatives to enhance healthcare access, presents significant opportunities for market growth.
Key players in the marketSome of the key players in Chronic Wound Care Market include 3M Healthcare, Advancis Medical, B. Braun, Cardinal Health, Coloplast, ConvaTec Group Plc, HARTMANN Group, Integra LifeSciences, Johnson & Johnson, Medline Industries, Misonix, Mölnlycke Health, Smith & Nephew and Tissue Regenix.
Key Developments:In May 2023, 3M is planning to invest nearly $150 million to advance capabilities in biopharma filtration technology. The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe. The new investment will accelerate 3M's development and delivery of vital filtration equipment designed for bioprocessing, biological and small molecule pharmaceutical manufacturing applications, which will enable biotech customers to continue to innovate therapies used for the treatment of conditions such as rheumatoid arthritis, multiple sclerosis and certain cancers.
In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. (""Pierrel""), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.
In January 2023, Mimedx entered into an exclusive distribution agreement with Gunze Medical Limited to sell placental tissue allograft, Epifix for wound healing in Japan. Upon this agreement, the company aims at strengthening its position in the Japan market.
Products Covered:
• Surgical Wound Care
• Traditional Wound Care
Types Covered:
• Wounds
• Ulcers
Applications Covered:
• Cleansing
• Antibiotics
• Debridement
• Therapy
• Other Applications
End Users Covered:
• Hospitals
• Specialty Clinics
• Home Healthcare
• Other End Users
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements